MIT, BASF test CheMeleon for low-data molecular prediction
MIT and BASF report that CheMeleon beat baselines in an evaluation of 58 molecular datasets and entered pharma workflows, but experimental testing remains necessary.
Topic
Topic
MIT and BASF report that CheMeleon beat baselines in an evaluation of 58 molecular datasets and entered pharma workflows, but experimental testing remains necessary.